Latest progress in treatment of chronic hepatitis B with tenofovir disoproxil fumarate
There are 400 million individuals infected with chronic hepatitis B virus (HBV) all over the world. The management of chronic hepatitis B (CHB) has been improved markedly over the last decade, primarily due to the availability of oral nucleoside analogue (NA) therapy. Among the numerous NAs, tenofov...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2015-04-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: |